Plate Nº 37 · recorded October 10, 2026

Biology & EvolutionReported finding

Immune 'false alarm' may drive rapid aging, study finds

Hebrew University researchers report that an overactive immune sensor, cGAS, may drive tissue decline in rare rapid-aging disorders. Lowering cGAS in animal models restored tissue function across multiple systems.

By James Calloway3 min read629 words

In brief

  1. Findings reported September 16, 2026, in the journal Genes, by a team led by Dr. Marva Bergman and Prof. Itamar Harel at the Hebrew University of Jerusalem.
  2. The study focused on rare DNA damage-repair syndromes including Ataxia-Telangiectasia and Bloom syndrome.
  3. Lowering activity of the immune sensor cGAS improved neuroinflammation, tissue degeneration, and reproductive capacity in a vertebrate model.
  4. cGAS can both trigger inflammation and physically interfere with DNA repair inside the cell nucleus, the researchers found.
  5. Any future therapy would need to reduce cGAS's harmful effects without weakening its essential role in detecting viruses.
Scientists find an immune “false alarm” that may drive rapid aging
Plate Nº 37Scientists find an immune “false alarm” that may drive rapid aging — AI-generated

An international team reported on September 16, 2026, that the body's mistaken immune response to DNA damage — not just broken DNA itself — may drive rapid tissue decline in severe genetic aging disorders. The team, led by Dr. Marva Bergman and Prof. Itamar Harel at the Hebrew University of Jerusalem, published its findings in the journal Genes.

The study focused on rare DNA damage-repair syndromes such as Ataxia-Telangiectasia (A-T) and Bloom syndrome. In people with these conditions, the cellular machinery that fixes routine DNA breaks does not work properly. Damaged DNA accumulates throughout the body, contributing to neurodegeneration, higher cancer risk, and premature aging.

What did the researchers actually find?

For decades, scientists assumed that unrepaired DNA was the main driver of decline. The new findings suggest a more complicated picture.

"Our results show that the damage isn't acting alone," Prof. Harel said. "It's the body's response to that damage, an exaggerated, chronic inflammatory reaction, that drives much of the degeneration."

The team also included Prof. Yehuda Tzfati and Prof. Ido Ben-Ami of Hebrew University and Sha'are Zedek Medical Center, along with Prof. Bérénice Benayoun of the University of Southern California.

Why does the immune system react to our own DNA?

When DNA repair fails, fragments of genetic material can escape into the cell's cytosol, the fluid compartment where they do not belong. There, they can activate a molecular sensor called cGAS.

Under normal conditions, cGAS helps defend the body against viruses by detecting foreign DNA. But the sensor cannot always distinguish viral genetic material from fragments of the body's own DNA. The result is "sterile" inflammation, meaning inflammation without an infection. Instead of protecting tissue, the prolonged immune response begins damaging it.

The researchers identified an additional role for cGAS. Beyond triggering inflammation, cGAS can enter the cell nucleus and directly disrupt DNA repair. So the same molecule contributes to decline in two ways: by promoting inflammation and by interfering with the machinery that fixes damaged DNA.

What happens when cGAS is turned down?

To test whether quieting this response could change the course of disease, the team used a fast-aging vertebrate model. This setup allowed them to study aging-related changes over a relatively short period.

Lowering cGAS activity improved three major disease features:

  • Neuroinflammation
  • Tissue degeneration
  • Loss of reproductive capacity

"We weren't just slowing decline," Dr. Bergman said. "We saw broad restoration of tissue function. It suggests that the body can cope with more DNA damage than we assumed, if the inflammatory response is kept in check."

Could this lead to new treatments?

The findings point to a possible shift in strategy. Treating DNA damage disorders may not require repairing every individual genetic lesion. Instead, future therapies could focus on controlling how the body reacts to that damage.

An important complication stands in the way. cGAS is also essential for detecting viral infections, so blocking the pathway entirely could weaken antiviral immunity. Any treatment would need to reduce cGAS's harmful effects while preserving its protective role.

What are the limits of the approach?

The researchers emphasize that reversing severe, disease-related degeneration is not the same as slowing the fundamental biological rate of aging. cGAS activity matters most when DNA damage already overwhelms the repair system.

Still, the implications could extend beyond rare genetic conditions. Chronic inflammation and genomic instability appear in many age-related diseases, suggesting that similar mechanisms may contribute to broader forms of decline.

The work builds on earlier studies from the same group examining how reproduction and developmental timing influence lifespan. Taken together, the findings support a broader idea: biological systems that help organisms grow and reproduce early in life can shape how long tissues remain healthy later on.

via dx.doi.org (Original)

Filed under

  • cgas
  • dna-damage-repair
  • premature-aging
  • sterile-inflammation
  • progeria
Share this article:

More from James Calloway

James Calloway

Show full bio

Staff writer covering marketplaces and e-commerce at SciBeat.

205 articles

Nearby plates

« Previous articleNext article »